Serum testosterone levels and clinical outcomes in male hemodialysis patients

American Journal of Kidney Diseases

Volumn 63, Issue 2, 2014, Pages 268-275

  Bello, Aminu K ^a   Stenvinkel, Peter ^b   Lin, Meng ^a   Hemmelgarn, Brenda ^c   Thadhani, Ravi ^d   Klarenbach, Scott ^a   Chan, Christopher ^e   Zimmerman, Deborah ^f   Cembrowski, George ^a   Strippoli, Giovanni ^g   Carrero, Juan Jesus ^b   Tonelli, Marcello ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF CALGARY   (Canada)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF OTTAWA   (Canada)

^g Mario Negri Sud Consortium ^*  (Italy)

Author keywords

adverse clinical outcomes; dialysis; health related quality of life (HRQoL); Serum testosterone

Indexed keywords

TESTOSTERONE; BIOLOGICAL MARKER;

ADULT; ARTICLE; DEATH; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; QUALITY OF LIFE; STRUCTURED INTERVIEW; TESTOSTERONE BLOOD LEVEL; YOUNG ADULT; AGED; BLOOD; CLINICAL TRIAL; COHORT ANALYSIS; PROCEDURES; PSYCHOLOGY; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME;

AGED; BIOLOGICAL MARKERS; COHORT STUDIES; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; RENAL DIALYSIS; TESTOSTERONE; TREATMENT OUTCOME;

EID: 84892933296     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2013.06.010     Document Type: Article

References (38)

1. A.B. Araujo, J.M. Dixon, E.A. Suarez, M.H. Murad, L.T. Guey, and G.A. Wittert Clinical review: endogenous testosterone and mortality in men: a systematic review and meta-analysis J Clin Endocrinol Metab 96 10 2011 3007 3019
2. S. Basaria, and A.S. Dobs Testosterone making an entry into the cardiometabolic world Circulation 116 23 2007 2658 2661
3. S. Bhasin, G.R. Cunningham, and F.J. Hayes et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline J Clin Endocrinol Metab 95 6 2010 2536 2559
4. C.A. Allan, and R.I. McLachlan Age-related changes in testosterone and the role of replacement therapy in older men Clin Endocrinol (Oxf) 60 6 2004 653 670
5. J.J. Carrero, P. Barany, and M.I. Yilmaz et al. Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease Nephrol Dial Transplant 27 2 2012 709 715
6. J.J. Carrero, A.R. Qureshi, and A. Nakashima et al. Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease Nephrol Dial Transplant 26 1 2011 184 190
7. G. Corona, M. Monami, and V. Boddi et al. Low testosterone is associated with an increased risk of MACE lethality in subjects with erectile dysfunction J Sex Med 7 4, pt 1 2010 1557 1564
8. O. Gungor, F. Kircelli, and J.J. Carrero et al. Endogenous testosterone and mortality in male hemodialysis patients: is it the result of aging? Clin J Am Soc Nephrol 5 11 2010 2018 2023
9. R. Haring, H. Volzke, and A. Steveling et al. Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79 Eur Heart J 31 12 2010 1494 1501
10. G. Jackson Testosterone deficiency syndrome (TDS) and the heart Eur Heart J 31 12 2010 1436 1437
11. D. Karakitsos, A.P. Patrianakos, and E. De Groot et al. Androgen deficiency and endothelial dysfunction in men with end-stage kidney disease receiving maintenance hemodialysis Am J Nephrol 26 6 2006 536 543
12. K.T. Khaw, M. Dowsett, and E. Folkerd et al. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European Prospective Investigation Into Cancer in Norfolk (EPIC-Norfolk) Prospective Population Study Circulation 116 23 2007 2694 2701
13. G.A. Laughlin, E. Barrett-Connor, and J. Bergstrom Low serum testosterone and mortality in older men J Clin Endocrinol Metab 93 1 2008 68 75
14. A.M. Traish, F. Saad, R.J. Feeley, and A. Guay The dark side of testosterone deficiency: III. Cardiovascular disease J Androl 30 5 2009 477 494
15. P.Y. Liu, A.K. Death, and D.J. Handelsman Androgens and cardiovascular disease Endocr Rev 24 3 2003 313 340
16. M. Maggio, F. Lauretani, and G.P. Ceda et al. Relationship between low levels of anabolic hormones and 6-year mortality in older men: the Aging in the Chianti Area (InCHIANTI) Study Arch Intern Med 167 20 2007 2249 2254
17. M. Muller, Y.T. van der Schouw, J.H. Thijssen, and D.E. Grobbee Endogenous sex hormones and cardiovascular disease in men J Clin Endocrinol Metab 88 11 2003 5076 5086
18. M.M. Shores, A.M. Matsumoto, K.L. Sloan, and D.R. Kivlahan Low serum testosterone and mortality in male veterans Arch Intern Med 166 15 2006 1660 1665
19. M.I. Yilmaz, A. Sonmez, and A.R. Qureshi et al. Endogenous testosterone, endothelial dysfunction, and cardiovascular events in men with nondialysis chronic kidney disease Clin J Am Soc Nephrol 6 7 2011 1617 1625
20. J.J. Carrero, and P. Stenvinkel The vulnerable man: impact of testosterone deficiency on the uraemic phenotype Nephrol Dial Transplant 27 11 2012 4030 4041
21. J.J. Carrero, A.R. Qureshi, and P. Parini et al. Low serum testosterone increases mortality risk among male dialysis patients J Am Soc Nephrol 20 3 2009 613 620
22. A.K. Bello, R. Thadhani, and B. Hemmelgarn et al. Design and implementation of the Canadian Kidney Disease Cohort Study (CKDCS): a prospective observational study of incident hemodialysis patients BMC Nephrol 12 2011 10
23. M. Drummond Introducing economic and quality of life measurements into clinical studies Ann Med 33 5 2001 344 349
24. B. Lunenfeld, F. Saad, and C.E. Hoesl ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale Aging Male 8 2 2005 59 74
25. M.V. Rocco, G. Yan, and J. Gassman et al. Comparison of causes of death using HEMO Study and HCFA end-stage renal disease death notification classification systems. The National Institutes of Health-funded Hemodialysis. Health Care Financing Administration Am J Kidney Dis 39 1 2002 146 153
26. H. Akaike [Data analysis by statistical models] No To Hattatsu 24 2 1992 127 133
27. A. Vermeulen, L. Verdonck, and J.M. Kaufman A critical evaluation of simple methods for the estimation of free testosterone in serum J Clin Endocrinol Metab 84 10 1999 3666 3672
28. Anonymous. 2010 CORR report -treatment of end-stage organ failure in Canada 1999 to 2008. https://secure.cihi.ca/estore/productFamily.htm?pf= PFC1403&locale=en&lang=EN&mediatype=0. Accessed November 30, 2012.
29. M.M. Fernandez-Balsells, M.H. Murad, and M. Lane et al. Clinical review 1: adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis J Clin Endocrinol Metab 95 6 2010 2560 2575
30. H.M. Behre, T.L. Tammela, and S. Arver et al. A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with 12 months open-label follow-up Aging Male 15 4 2012 198 207
31. J.L. Tostain, and F. Blanc Testosterone deficiency: a common, unrecognized syndrome Nat Clin Pract Urol 5 7 2008 388 396
32. J.B. Krasnoff, S. Basaria, and M.J. Pencina et al. Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring Study J Clin Endocrinol Metab 95 6 2010 2790 2799
33. Cigarran S, Pousa M, Castro MJ, et al. Endogenous testosterone, muscle strength, and fat-free mass in men with chronic kidney disease [published online ahead of print October 6, 2012]. J Ren Nutr. http://dx.doi.org/10.1053/j.jrn. 2012.08.007.
34. M. Miner, D.J. Canty, and R. Shabsigh Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices Postgrad Med 120 3 2008 130 153
35. P. Grootendorst, D. Feeny, and W. Furlong Health Utilities Index Mark 3: evidence of construct validity for stroke and arthritis in a population health survey Med Care 38 3 2000 290 299
36. R.W. Evans, D.L. Manninen, and L.P. Garrison Jr. et al. The quality of life of patients with end-stage renal disease N Engl J Med 312 9 1985 553 559
37. M. Vecchio, S.D. Navaneethan, and D.W. Johnson et al. Treatment options for sexual dysfunction in patients with chronic kidney disease: a systematic review of randomized controlled trials Clin J Am Soc Nephrol 5 6 2010 985 995
38. M. Vecchio, S.C. Palmer, M. Tonelli, D.W. Johnson, and G.F. Strippoli Depression and sexual dysfunction in chronic kidney disease: a narrative review of the evidence in areas of significant unmet need Nephrol Dial Transplant 27 9 2012 3420 3428